Article info
Original research
Overexpression of integrin alpha 2 (ITGA2) correlates with poor survival in patients with pancreatic ductal adenocarcinoma
- Correspondence to Dr Steffen Deichmann, Department of Surgery, University Medical Center Schleswig Holstein Lübeck Campus, 23538 Lubeck, Germany; steffen.deichmann{at}uksh.de
Citation
Overexpression of integrin alpha 2 (ITGA2) correlates with poor survival in patients with pancreatic ductal adenocarcinoma
Publication history
- Received January 21, 2022
- Accepted March 7, 2022
- First published April 8, 2022.
Online issue publication
October 18, 2023
Article Versions
- Previous version (19 July 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.